Lewis David F V
School of Biomedical and Life Sciences, University of Surrey, Guildford, UK.
J Inorg Biochem. 2002 Sep 20;91(4):502-14. doi: 10.1016/s0162-0134(02)00429-4.
A historical background to homology modelling of human P450s involved in drug metabolism is outlined, showing that the progress in crystallographic studies of bacterial forms of enzyme and, latterly, determination of a mammalian P450 crystal structure, has enabled the production of increasingly satisfactory models of human P450 enzymes. The methodology for the generation of P450 models by homology with crystallographic template structures is summarized, and recent results of CYP2C5-constructed models of P450s are described. These indicate that selective substrates are able to fit within the putative active sites of each enzyme, where key contacts with complementary amino acid residues are largely consistent with the results of site-directed mutagenesis experiments and metabolic studies. Consequently, the CYP2C5 crystal structure can be regarded at the current paradigm for homology modelling of the drug metabolizing P450s, especially those from the CYP2 family.
本文概述了参与药物代谢的人类细胞色素P450(P450)同源建模的历史背景,表明细菌形式酶的晶体学研究进展以及后来哺乳动物P450晶体结构的确定,使得人类P450酶模型越来越令人满意。总结了通过与晶体学模板结构同源性生成P450模型的方法,并描述了最近构建的CYP2C5 P450模型的结果。这些结果表明,选择性底物能够契合每种酶的假定活性位点,在该位点与互补氨基酸残基的关键接触在很大程度上与定点诱变实验和代谢研究的结果一致。因此,CYP2C5晶体结构可被视为目前药物代谢P450同源建模的范例,尤其是来自CYP2家族的那些。